Cavos Biotech is developing a multi-level genomic algorithm to uncover the genetic base of extraordinary cancer resistance found across various and specific animals.

Harnessing the latest in data and genomics, the company uses high-resolution identification methods to uncover existing anti-cancer mechanisms and novel drug targets in order to revolutionize the way drug targets are discovered and identified.